Skip to main content
. 2025 May 30;61(6):1021. doi: 10.3390/medicina61061021
Cancer
Metformin
Neoplasms
Prevention
Carcinoma
Risk
Incidence
Bisguanides
Type two Diabetes
Hypoglycaemic agents
Chemotherapy
Metformin monotherapy
Mortality